Metabolic clues: could your Body's energy use predict ovarian cancer outcomes?

NCT ID NCT07764133

Recruiting now Knowledge-focused Sponsor: University of Tennessee Graduate School of Medicine Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study investigates whether measuring whole-body metabolism—how the body uses energy—can reflect the metabolic changes in ovarian tumors and predict how well patients respond to chemotherapy. Researchers will measure resting metabolic rate and other metabolic markers in women with suspected epithelial ovarian cancer before and during treatment. The goal is to find non-invasive ways to understand tumor metabolism and potentially identify new targets to restore chemotherapy sensitivity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a non-invasive way to predict how well ovarian cancer responds to chemotherapy, potentially guiding more personalized treatment plans.
What could go wrong: This is an early-stage observational study with a small number of participants. It may not establish a clear link, and findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Carcinoma, Ovarian Epithelial ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPITHELIAL OVARIAN CANCER

Contacts and locations

Locations

University of Tennessee Medical Center - Knoxville
RECRUITING

Knoxville, Tennessee, 37920, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.